The GABAA receptor agonist THIP is neuroprotective in organotypic hippocampal slice cultures

被引:23
作者
Kristensen, BW [1 ]
Noraberg, J [1 ]
Zimmer, J [1 ]
机构
[1] Univ So Denmark, Inst Med Biol, Neuroscreen ApS, DK-5000 Odense C, Denmark
关键词
excitotoxicity; experimental ischemia; explant culture; gamma-aminobutyric acid; neurodegeneration; propidium iodide; GluR5;
D O I
10.1016/S0006-8993(03)02550-2
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The potential neuroprotective effects of the GABA(A) receptor agonists THIP (4,5,6,7-tetrahydroisoxazolo[5,4-c]pyridin-3-ol) and muscimol, and the selective GluR5 kainate receptor agonist ATPA ((RS)-2-amino-3-(3-hydroxy-5-tert-butylisoxazol-4-yl)propanoic acid), which activates GABAergic interneurons, were examined in hippocampal slice cultures exposed to N-methyl-D-aspartate (NMDA). The NMDA-induced excitotoxicity was quantified by densitometric measurements of propidium iodide (PI) uptake. THIP (100-1000 muM) was neuroprotective in slice cultures co-exposed to NMDA (10 muM) for 48 h, while muscimol (100-1000 muM) and ATPA (1-3 muM) were without effect. The results demonstrate that direct GABA(A) agonism can mediate neuroprotection in the hippocampus in vitro as previously suggested in vivo. (C) 2003 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:303 / 306
页数:4
相关论文
共 27 条
[1]   Nuclear shrinkage and other markers of neuronal cell death after oxygen-glucose deprivation in rat hippocampal slice cultures [J].
Bonde, C ;
Noraberg, J ;
Zimmer, J .
NEUROSCIENCE LETTERS, 2002, 327 (01) :49-52
[2]   GDNF and neublastin protect against NMDA-induced excitotoxicity in hippocampal slice cultures [J].
Bonde, C ;
Kristensen, BW ;
Blaabjerg, M ;
Johansen, TE ;
Zimmer, J ;
Meyer, M .
NEUROREPORT, 2000, 11 (18) :4069-4073
[3]   A hippocampal GluR5 kainate receptor regulating inhibitory synaptic transmission [J].
Clarke, VRJ ;
Ballyk, BA ;
Hoo, KH ;
Mandelzys, A ;
Pellizzari, A ;
Bath, CP ;
Thomas, J ;
Sharpe, EF ;
Davies, CH ;
Ornstein, PL ;
Schoepp, DD ;
Kamboj, RK ;
Collingridge, GL ;
Lodge, D ;
Bleakman, D .
NATURE, 1997, 389 (6651) :599-603
[4]  
COSSART R, 1999, NAT NEUROSCI, V1, P579
[5]   Clinical trials with neuroprotective drugs in acute ischaemic stroke: are we doing the right thing? [J].
De Keyser, J ;
Sulter, G ;
Luiten, PG .
TRENDS IN NEUROSCIENCES, 1999, 22 (12) :535-540
[6]  
EBERT B, 1994, MOL PHARMACOL, V46, P957
[7]   PARTIAL GABA(A) RECEPTOR AGONISTS - SYNTHESIS AND IN-VITRO PHARMACOLOGY OF A SERIES OF NONANNULATED ANALOGS OF 4,5,6,7-TETRAHYDROISOXAZOLO[5,4-C]PYRIDIN-3-OL [J].
FROLUND, B ;
KRISTIANSEN, U ;
BREHM, L ;
HANSEN, AB ;
KROGSGAARDLARSEN, P ;
FALCH, E .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (17) :3287-3296
[8]  
Frolund Bente, 2002, Current Topics in Medicinal Chemistry, V2, P817, DOI 10.2174/1568026023393525
[9]   Clomethiazole (Zendra®) in acute ischemic stroke:: Basic pharmacology and biochemistry and clinical efficacy [J].
Green, AR .
PHARMACOLOGY & THERAPEUTICS, 1998, 80 (02) :123-147
[10]  
JOHANSEN FF, 1991, ACTA NEUROL SCAND, V84, P1